Cris De Luca

Sanofi Ventures thesis

Our Approach As the corporate venture capital arm of Sanofi, we invest in top-tier biotech and digital health companies that focus on helping patients and transforming the practice of medicine. We invest across all stages of the private company lifecycle, from Seed to Series B and beyond, while leading financings, serving on boards, and taking pride in working alongside portfolio companies to drive long-term value through future financings and IPO. Our raison d' ê tre We invest in the innovators behind the miracles of science who are passionate about improving human health. Sanofi Ventures ser

Sector and stage focus

• Series B: Consumer Health, AI, Direct-to-Consumer (DTC), Generative Tech/AI, Medical Devices, IoT, Pharmaceuticals, Diagnostics, Digital Health, Health IT
• Series A: Direct-to-Consumer (DTC), Generative Tech/AI, Consumer Health, Medical Devices, IoT, Pharmaceuticals, Health IT, AI, Diagnostics, Digital Health
• general: Diverse Investors, Investors who were founders, Investors who invested in female founders, Israel, Investors who invested in diverse founders, New York City, San Francisco Bay Area, Boston / New England

Recent investments by Cris De Luca

Cris De Luca has 1 named past investments in the public record. The most recent:

Is Cris De Luca a fit for your round?

Upload your pitch deck and see whether Cris De Luca appears in your top 20 matches.